iShares Biotechnology ETF (IBB) |
126.49 0.82 (0.65%) 04-26 16:00 |
Open: | 125.95 |
High: | 126.925 |
Low: | 125.052 |
Volume: | 831,976 |
Market Cap: | 8,816(M) |
PE Ratio: | 16.51 |
Exchange: | NASDAQ Global Market |
Industry: | Asset Management |
Sector: | Financial Services |
Technical analysis | ||||
sell | buy |
Resistance 2: | 138.40 |
Resistance 1: | 132.75 |
Pivot price: | 128.32 |
Support 1: | 123.60 |
Support 2: | 102.84 |
52w High: | 141.16 |
52w Low: | 111.83 |
The fund generally will invest at least 80% of its assets in the component securities of its index and in investments that have economic characteristics that are substantially identical to the component securities of its index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
EPS | 0.000 |
Book Value | 0.000 |
PEG Ratio | 0.00 |
Gross Profit | 0.000 |
Profit Margin (%) | 0.00 |
Operating Margin (%) | 0.00 |
Return on Assets (ttm) | 0.0 |
Return on Equity (ttm) | 0.0 |
Sat, 20 Apr 2024
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now? - Yahoo Movies Canada
Wed, 17 Apr 2024
Should You Invest in the iShares Biotechnology ETF (IBB)? - Yahoo Singapore News
Thu, 28 Mar 2024
Should You Invest in the iShares Biotechnology ETF (IBB)? - Zacks Investment Research
Tue, 19 Mar 2024
3 Biotech ETFs Overdue for a Bounce - InvestorPlace
Thu, 29 Feb 2024
This biotech ETF sees 'breakout' while U.S. small-cap technology stocks lag - Morningstar
Thu, 29 Feb 2024
7 Best Biotech ETFs to Buy Now | Investing | U.S. News - U.S News & World Report Money
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |